Algernon Pharmaceuticals (TSE:AGN) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Algernon Pharmaceuticals invites stakeholders to a special CEO interview and Q&A session with CEO Christopher J. Moreau, hosted by Market Radius Research on April 16th, 2024. The discussion will cover the recent Ifendprodil deal and future plans for the company’s DMT stroke research. Attendees can interact live or access the archived webcast later.
For further insights into TSE:AGN stock, check out TipRanks’ Stock Analysis page.